Bcl-2 family proteins are key intracellular regulators of programmed cell death. Several recent discoveries demonstrate how these proteins interact with the molecular machinery that controls and executes the cell-death programme, and how they can themselves be regulated by extracellular survival signals.
I shall discuss three recent advances in our understanding of Bcl-2 proteins. First, and most exciting, is the finding that the Bcl-2 proteins CED-9 and Bcl-XL can physically interact with the C. elegans cell-death protein CED-4, which itself binds directly to caspases. Second is the finding that Bcl-2 and Bcl-XL regulate the release of cytochrome c from mitochondria to the cytosol, thereby preventing the activation of caspases by cytochrome c. Third is the finding that Bcl-2 proteins can be regulated by phosphorylation, providing a link from extracellular signals, via intracellular kinase-mediated signalling cascades, to the machinery that actually kills the cell.
Interactions between Bcl-2 proteins, CED-4 and caspases
The recent discovery that CED-9 physically interacts with CED-4 [3] [4] [5] [6] and, furthermore, that CED-4 can independently bind to CED-3/caspases [5] , provides the first physical link between Bcl-2 proteins and the cell-death machinery. The new findings suggest that Bcl-2 proteins directly regulate the activation of caspases via CED-4, which acts as an adaptor protein. This model is consistent with genetic studies of programmed cell death in C. elegans, which had already suggested that CED-4 acts Genetic analysis in the nematode C. elegans suggests that ced-9, which encodes a Bcl-2-related protein, acts upstream of ced-4 and ced-3; consistent with this, Bcl-2 and Bcl-XL have been found to act biochemically upstream of some of the caspases. between CED-9 and CED-3, with CED-9 upstream (Fig. 1) . CED-4 is required, for example, for CED-9 to inhibit CED-3; indeed, splicing variants of CED-4 determine whether CED-9 activates or suppresses cell death. The model is also consistent with the biochemical evidence that Bcl-2 and Bcl-XL act upstream of some of the caspases in mammalian cells.
The physical association between CED-9 and CED-4 was demonstrated by complementary techniques -yeast twohybrid assays [3, 4, 6] , coimmunoprecipitation [4] [5] [6] and colocalization [3, 6] . When expressed in transfected mammalian cells, CED-4 induces programmed cell death [5] ; this can be blocked both by caspase inhibitors and CED-9, indicating that CED-4 can act in mammalian cells in the same way that it does in C. elegans. Furthermore, Bcl-XL can also bind to CED-4, and, like CED-9, it inhibits CED-4 function [5] . Mutations in CED-9 or Bcl-XL that disrupt their ability to interact with CED-4 also abolish their ability to suppress programmed cell death [4, 5] . Thus, the interactions between CED-9/Bcl-2 proteins and CED-4 are evolutionarily conserved between nematodes and humans, strongly suggesting that there is a CED-4 homologue in vertebrates.
How does cytosolic CED-4 induce cell death? To promote cell death in C. elegans, CED-4 requires CED-3, and its ability to induce programmed cell death in mammalian cells depends on caspase activity. Chinnaiyan et al. [5] therefore looked for evidence of a physical interaction between CED-4 and CED-3. They found that CED-4 can bind directly to CED-3, as well as to two mammalian caspases, ICE (caspase-1) and FLICE (caspase-8), but not to the caspases CPP32 (caspase-3) or Mch2 (caspase-6). These interactions were independent of CED-4's ability to associate with CED-9; indeed, CED-9 and CED-3 could be coimmunoprecipitated from cytosol, but only if CED-4 was coexpressed, indicating that a complex can form containing all three proteins. Bcl-XL, by contrast, was able to associate with ICE and FLICE in the absence of CED-4, but did not bind to them directly, indicating that an unidentified endogenous cytosolic factor acts as a linker. Expression of CED-4 did not enhance this interaction, but a truncated form of CED-4 that can bind to CED-3 but not CED-9 disrupted it, providing further support for the idea that the endogenous linking protein might be a CED-4 homologue. The next step will be to identify and characterize this protein and to determine whether it is indeed a mammalian CED-4. The identification of specific regions of two independent types of interacting protein -CED-9/Bcl-2 proteins and caspases -will greatly facilitate this search.
CED-4's ability to interact with CED-3, ICE and FLICE was found to depend on the presence of a large aminoterminal domain, known as the pro-domain, that is present in these caspases and is cleaved off when they are activated by proteolytic cleavage. Both of the non-interacting caspases, CPP32 and Mch2, have small pro-domains, whereas CED-3, ICE and FLICE all have large prodomains. Even in isolation from the rest of the protein, the pro-domain of CED-3 could associate with CED-4, suggesting that this region of the protein is in important site of interaction.
The subcellular localization of CED-4 is consistent with a physical interaction with CED-9/Bcl-2 proteins in vivo. When expressed in yeast or mammalian cells, CED-4 is cytosolic, but when coexpressed with CED-9, it localizes to the same intracellular sites as CED-9 [3, 6] . Binding to CED-9 (or Bcl-XL) thus sequesters CED-4 from the cytosol and inhibits its ability to activate caspases. The simplest model consistent with these findings (Fig. 2) is that anti-apoptotic CED-9/Bcl-2 proteins sequester inactive pro-CED-3/caspases, via CED-4 linker proteins, at intracellular membrane sites, thereby preventing them from activating downstream cytosolic caspases.
This model for inhibition of caspases is reminiscent of the way the cell-surface receptor CD95 (Fas/Apo-1) activates the caspase FLICE by recruiting pro-FLICE to a protein complex at the plasma membrane and releasing active FLICE into the cytosol (reviewed in [7] ). The active CD95 complex recruits adaptor proteins that bind to the FLICE pro-domain. Interestingly, the 'death effector domains' in the pro-domain of FLICE and in the adaptor protein FADD/MORT1 both have sequence similarities to a region of CED-4, which had suggested that these proteins might physically interact [7] . The idea that Bcl-2 proteins regulate the death programme by controlling the ability of CED-4 to activate caspases is supported by the observation that pro-apoptotic Bcl-2 proteins disrupted the interaction between Bcl-XL and CED-4, without themselves binding to CED-4 [5] ; presumably their binding to Bcl-XL displaces CED-4 (Fig. 2) .
Bcl-2 can block release of cytochrome c from mitochondria
Since Bcl-2 was shown to be localized to mitochondrial membranes, these organelles have often been at the centre of attention and controversy in the cell-death field; they have also been involved in many false leads and purported breakthroughs in our understanding of Bcl-2 function. Two recent papers, by Yang et al. [8] and by Kluck et al. [9] , have now provided convincing evidence suggesting that mitochondria may play a direct role in programmed cell death, by releasing cytochrome c in response to deathinducing signals. By inhibiting this release, Bcl-2 and Bcl-XL may prevent cytochrome c from activating caspases in the cytosol, and thereby suppress programmed cell death.
Several lines of evidence indicated that mitochondria are important for Bcl-2 function. Removal of the carboxyterminal, membrane-targeting domain of Bcl-2 inhibits its ability to suppress programmed cell death, and targeting the protein to a specific organelle -mitochondria or endoplasmic reticulum (ER) -seems to be necessary for it to work [10] . One of the most convincing pieces of evidence that mitochondria are important for Bcl-2 function comes from studying a cell-free programmed cell death system based on Xenopus egg extracts, where it has been found that Bcl-2 can inhibit nuclei from undergoing apoptotic changes only if a mitochondrial fraction is also present [11] . Which of the many mitochondrial functions are important for programmed cell death?
Kroemer et al. [12] have suggested that the loss of mitochondrial membrane potential and the opening of large pores, called permeability transition channels, is important during programmed cell death. Bcl-2 can inhibit both this loss of membrane potential and the release of factors from mitochondria into the cytosol that can activate caspases [13] . The idea that the release of mitochondrial caspase-activating proteins might be an important point of control by Bcl-2 proteins gained further support when Liu et al. [14] purified proteins released from mitochondria in a cell-free programmed cell death system and identified one of them as cytochrome c.
Yang et al. [8] and Kluck et al. [9] have now extended this finding. Both groups found that Bcl-2 and Bcl-XL prevented cytochrome c release upon induction of programmed cell death in intact cells and cell-free systems. Bcl-2 and Bcl-XL were effective only on the mitochondria on which they were located [9] , and they could not inhibit apoptotic changes induced by cytochrome c after it was released or if it was added exogenously, supporting the idea that they exert their effect on mitochondria rather than the cytosol. The released cytochrome c appears to cooperate with other cytosolic factors to activate caspases, and may thereby induce programmed cell death: cytochrome c, in the presence of cytosol, can activate CPP32 in vitro [14] , and caspase inhibitors can block programmed cell death in cells even under conditions in which cytochrome c is released into the cytosol [9] . Importantly, both groups observed cytochrome c release without loss of mitochondrial membrane potential, which suggests that the potential loss is not required for programmed cell death and rules out the possibility that cytochrome c release requires opening of the permeability transition channels or is simply an artefact of mitochondrial damage, which would also cause loss of membrane potential.
The idea that a cytochrome might be important in the suppression of programmed cell death by Bcl-2 proteins was previously suggested, again by evidence from C. elegans, where ced-9 is in the same transcription unit as a cytochrome-encoding gene [15] . Cytochrome c can now be added to the list of important biochemical elements of the cell-death machinery, and many new questions are raised. What is the mechanism by which cytochrome c is released from mitochondria, and how do Bcl-2 and Bcl-XL prevent this release? How does cytochrome c activate caspases? Does the ER similarly release a caspaseactivating factor into the cytosol? One speculation is that ion homeostasis in mitochondria might be involved in some way, a notion supported by the observed pore-like structure [16] and ion-channel-forming properties [17] of Bcl-XL. This pore-like structure has also raised the possibility that these Bcl-2 proteins might, like the poreforming protein perforin, regulate the passage of proteins involved in activating the death programme [18] .
Post-translational regulation of Bcl-2 proteins
We have seen that Bcl-2 proteins are important guardians of the death programme: they control at least two caspaseactivating proteins and, at least where it has been possible to test the hypothesis, as in C. elegans, they are essential for cell survival. But what controls the guardians? If, as seems likely, extracellular signals are required to suppress the death programme in every cell, then one would expect these signals to work, at least in part, by regulating Bcl-2 proteins. One way of doing this is by phosphorylation: it is clear that Bcl-2 can be phosphorylated on serine residues in response to a variety of stimuli (reviewed in [19] ). Phosphorylation of Bcl-2 occurs within a flexible loop region which appears to be a regulatory domain. Deletion of this loop domain enhances the action of Bcl-2 and Bcl-XL as suppressors of programmed cell death and enables Bcl-2 to suppress programmed cell death in at least one case where it is normally ineffective [20] . Bcl-2 proteins may also be regulated by proteolytic cleavage: Bcl-2 can be cleaved by human immunodeficiency virus-1 (HIV-1) proteases in vitro, and is cleaved during HIV-1-infection of lymphocytes, which may explain how these cells are induced to die [21] though it is not clear whether Bcl-2 cleavage is absolutely required for the apoptotic death of HIV-infected cells.
The regulation of Bcl-2 proteins by post-translational modification helps to resolve several puzzling observations. The relative levels of anti-apoptotic and pro-apoptotic Bcl-2 proteins can influence the propensity of a cell to live or die, for example, but this is not always an accurate predictor: there are cases where Bcl-2 overexpression does not protect against programmed cell death, or where one programmed-cell-death-suppressor is effective but another is not (reviewed in [19] ). Furthermore, some survival factors can work independently of the levels of Bcl-2 proteins -this is true of the protection of fibroblasts by insulin-like growth factor 1 (IGF-1) [22] and of ciliary neurons by ciliary neurotrophic factor (CNTF) [23] . Many of these seemingly contradictory observations make more sense if one considers that Bcl-2 proteins can be modulated by post-translational modifications.
Do such modifications also provide a link between extracellular and intracellular regulators of cell survival and death? The best evidence for such a link comes from a study by Zha et al. [24] , which suggests that the cytokine interleukin-3 (IL-3) promotes cell survival by phosphorylating the pro-apoptotic protein Bad (see Fig. 3 Bad phosphorylation and cell survival can also be promoted by activation of Raf-1 [25] , a serine/threonine kinase which normally forms part of the mitogen-activated protein (MAP) kinase cascade and which is activated by Ras-dependent signalling pathways. Raf-1 can associate with Bcl-2 in vivo [26] , suggesting that it might activate a kinase cascade associated in a complex with Bcl-2 at mitochondrial and other intracellular membrane sites, resulting in phosphorylation of Bad and promotion of cell survival.
A molecular framework for programmed cell death
It thus seems clear that phosphorylation of Bcl-2 proteins is one way that the cell-death programme is regulated and is an important way by which some survival factors can suppress programmed cell death. The recent discoveries concerning CED-4 and cytochrome c indicate at least two ways that Bcl-2 proteins regulate caspase activation: by binding to and inhibiting CED-4, and by preventing the release of cytochrome c into the cytosol. The genetics of programmed cell death in C. elegans have thus proved powerfully predictive. Now, at last, the molecular framework of programmed cell death and its regulation are falling into place.
